D. Boral Capital acted as Exclusive Placement Agent to Luminar Technologies (NASDAQ: LAZR) in connection with its up to $200.0 Million Equity Linked Securities Offering
D. Boral Capital Acted as Sole Bookrunner to Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) in connection with its $13.5 Million Initial Public Offering
D. Boral Capital is Acting as Exclusive Placement Agent to Nature’s Miracle Holding Inc. (NYSE: NMHI) in connection with its Private Placement for up to $20 Million